The Company is maintaining its full year 2025 outlook for Organic Revenue Growth Rate and Adjusted EBITDAC Margin as follows: Organic Revenue Growth Rate guidance for full year 2025 is between 11.0% – 13.0%; Adjusted EBITDAC Margin guidance for full year 2025 is between 32.5% – 33.5%
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target lowered to $83 from $88 at Barclays
- Ryan Specialty price target raised to $78 from $75 at Morgan Stanley
- Ryan Specialty initiated with a Buy at TD Cowen
- Ryan Specialty price target lowered to $66 from $69 at Wells Fargo
- Ryan Specialty price target lowered to $75 from $76 at Keefe Bruyette
